Safety of Eptifibatide for Subcortical Stroke Progression

BACKGROUND: There is no proven treatment for stroke progression in patients with subcortical infarcts. Eptifibatide, a glycoprotein IIb/IIIa inhibitor, might halt stroke progression by improving flow in the microcirculation. METHODS: We conducted a retrospective analysis of patients with subcortical...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Martin-Schild, Sheryl, Shaltoni, Hashem, Abraham, Anitha T., Barreto, Andrew D., Hallevi, Hen, Gonzales, Nicole R., Grotta, James C., Savitz, Sean I.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: S. Karger AG 2009
Aiheet:
Original Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2914354/
https://ncbi.nlm.nih.gov/pubmed/19844100
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000247604
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia